J. Guan, Long, L., Chen, Y. - Q., Yin, Y., Li, L., Zhang, C. - X., Deng, L., and Tian, L. - H.
, “Effects of beraprost sodium on renal function and inflammatory factors of rats with diabetic nephropathy”
, vol. 13, pp. 4154-4158, 2014.
Beraprost sodium (BPS) is a prostaglandin analogue. We investigated its effects on rats with diabetic nephropathy. There were 20 rats each in the normal control group (NC), the diabetic nephropathy group (DN), and the BPS treatment group. The rats in DN and BPS groups were given a high-fat diet combined with low-dose streptozotocin intraperitoneal injections. The rats in the BPS group were given daily 0.6 mg/kg intraperitoneal injections of this drug.